These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6891737)

  • 21. Stereotypy and striatal dopamine receptor changes with 1-alpha-acetylmethadol (LAAM).
    Langley AE; Kirlangitis J; Lehman T
    Pharmacol Biochem Behav; 1981 May; 14(5):753-6. PubMed ID: 7195581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intragastric administration of cyclo(Leu-Gly) inhibits the development of tolerance to the analgesic effect of morphine in the rat.
    Bhargava HN
    Life Sci; 1988; 43(2):187-92. PubMed ID: 3393061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged inhibition of striatal dopamine receptor sites by isofloxythepin.
    Lau YS; Runice C
    Eur J Pharmacol; 1985 Oct; 116(1-2):25-31. PubMed ID: 2865162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclo (Leu-Gly) + haloperidol: effects on dopamine receptors and conditioned avoidance responding.
    Bean AJ; Elgin RJ; Cooper DM; Martin GE
    Peptides; 1987; 8(1):39-44. PubMed ID: 3575153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
    Pert A; Rosenblatt JE; Sivit C; Pert CB; Bunney WE
    Science; 1978 Jul; 201(4351):171-3. PubMed ID: 566468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
    Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
    Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of narcotic tolerance and physical dependence: effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly).
    Bhargava HN; Walter R; Ritzmann RF
    Pharmacol Biochem Behav; 1980 Jan; 12(1):73-7. PubMed ID: 6102769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity?
    Ferretti C; Ghi P; Blengio M; Gaietta G; Barrera G; Genazzani E
    Eur J Pharmacol; 1989 Jul; 166(2):149-56. PubMed ID: 2551698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does chronic morphine treatment induce a supersensitivity of dopamine receptors in rat brain?
    Kuschinsky K
    Psychopharmacologia; 1975 Jun; 42(3):225-9. PubMed ID: 1172252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radio-frequency analysis of the effect of haloperidol and cyclo (leucyl-glycyl) on apomorphine-induced stereotypy.
    Fields JZ; Gonzalez LP; Meyerson LR; Lieber P; Lee JM; Steece KA; DeLeon-Jones FA; Ritzmann RF
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1279-84. PubMed ID: 3809231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity.
    Cameron DL; Crocker AD
    Neurosci Lett; 1988 Jul; 90(1-2):165-71. PubMed ID: 3045699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a role of endogenous opioids in the nigrostriatal system: influence of naloxone and morphine on nigrostriatal dopaminergic supersensitivity.
    Hirschhorn ID; Hittner D; Gardner EL; Cubells J; Makman MH
    Brain Res; 1983 Jun; 270(1):109-17. PubMed ID: 6409355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term changes of striatal D-2 receptors in rats chronically exposed to morphine under aversive life conditions.
    Kiyatkin EA; Belyi VP; Rusakov DYu ; Maksimov VV; Pankratova NV; Rozhanets VV
    Int J Neurosci; 1991 May; 58(1-2):55-61. PubMed ID: 1834600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronically administered morphine increases dopamine receptor sensitivity in mice.
    Martin JR; Takemori AE
    Eur J Pharmacol; 1986 Feb; 121(2):221-9. PubMed ID: 3699094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A permanent dopamine receptor up-regulation in the ovariectomized rat.
    Gordon JH; Fields JZ
    Pharmacol Biochem Behav; 1989 May; 33(1):123-5. PubMed ID: 2780771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
    Sibley DR; Weinberger S; Segal DS; Creese I
    Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aging and the regulation of striatal dopaminergic mechanisms in mice.
    Randall PK; Severson JA; Finch CE
    J Pharmacol Exp Ther; 1981 Dec; 219(3):695-700. PubMed ID: 7197719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.